Kenji Hayashihara

616 total citations
46 papers, 380 citations indexed

About

Kenji Hayashihara is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Kenji Hayashihara has authored 46 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Kenji Hayashihara's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13 papers), Lung Cancer Treatments and Mutations (13 papers) and Lung Cancer Research Studies (11 papers). Kenji Hayashihara is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13 papers), Lung Cancer Treatments and Mutations (13 papers) and Lung Cancer Research Studies (11 papers). Kenji Hayashihara collaborates with scholars based in Japan. Kenji Hayashihara's co-authors include Takefumi Saito, Akimasa Sekine, Hiroaki Satoh, Tae Iwasawa, Katsumi Tamura, Takashi Ogura, Terufumi Kato, Yukiko Miura, Toru Tanaka and Takeshi Shinohara and has published in prestigious journals such as Journal of Clinical Oncology, CHEST Journal and European Respiratory Journal.

In The Last Decade

Kenji Hayashihara

39 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kenji Hayashihara Japan	9	316	170	57	55	48	46	380
Naoko Morishita Japan	14	400 1.3×	260 1.5×	15 0.3×	38 0.7×	63 1.3×	62	586
Akira Hyogotani Japan	8	169 0.5×	78 0.5×	19 0.3×	55 1.0×	30 0.6×	17	299
D. Carmier France	9	227 0.7×	81 0.5×	146 2.6×	89 1.6×	47 1.0×	18	351
Makiko Yomota Japan	11	206 0.7×	172 1.0×	14 0.2×	23 0.4×	30 0.6×	39	302
Andrew M. Schreiner United States	11	138 0.4×	107 0.6×	24 0.4×	42 0.8×	84 1.8×	20	357
Mitsunori Morita Japan	9	265 0.8×	292 1.7×	15 0.3×	72 1.3×	14 0.3×	18	406
Tomonori Moritaka Japan	11	218 0.7×	179 1.1×	21 0.4×	35 0.6×	55 1.1×	29	325
Osamu Hiranuma Japan	10	174 0.6×	261 1.5×	10 0.2×	38 0.7×	31 0.6×	34	342
Arnold Cyjon Israel	8	327 1.0×	296 1.7×	13 0.2×	19 0.3×	65 1.4×	18	435
Kazimierz Roszkowski Poland	7	328 1.0×	298 1.8×	13 0.2×	25 0.5×	48 1.0×	19	421

Countries citing papers authored by Kenji Hayashihara

Since Specialization

Citations

This map shows the geographic impact of Kenji Hayashihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Hayashihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Hayashihara more than expected).

Fields of papers citing papers by Kenji Hayashihara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Hayashihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Hayashihara. The network helps show where Kenji Hayashihara may publish in the future.

Co-authorship network of co-authors of Kenji Hayashihara

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Hayashihara. A scholar is included among the top collaborators of Kenji Hayashihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Hayashihara. Kenji Hayashihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Okuma, Yusuke, Kaoru Kubota, Mototsugu Shimokawa, et al.. (2023). First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon EGFR Mutations. JAMA Oncology. 10(1). 43–43. 39 indexed citations

Okuma, Yusuke, Kaoru Kubota, Mototsugu Shimokawa, et al.. (2023). Uncommon EGFR mutations conducted with osimertinib in patients with NSCLC (UNICORN): A phase 2 study.. Journal of Clinical Oncology. 41(16_suppl). 9045–9045. 1 indexed citations

Hiroshima, Kenzo, Jun Kanazawa, Kenji Hayashihara, et al.. (2022). Usefulness of malignant pleural effusion for early cytological diagnosis of mesothelioma in situ: A case report. Oncology Letters. 24(6). 440–440. 3 indexed citations

Saito, Takefumi, H. Hirano, Jun Kanazawa, et al.. (2022). Impact of sleep-related hypoventilation in patients with pleuroparenchymal fibroelastosis. Respiratory Research. 23(1). 295–295. 3 indexed citations

Nakagawa, Takayuki, Shingo Usui∥, Kenji Hayashihara, et al.. (2020). A Case of Pulmonary Metastasis of Breast Cancer 23 Years after Surgery Accompanied with Non-Tuberculous Mycobacterium Infection. Case Reports in Oncology. 13(3). 1357–1363.

Goto, Hitomi, Tatsuya Akiyama, Hiroaki Ishikawa, et al.. (2019). Ein Fall von Aluminose der Atemwege mit wahrscheinlich sekundärer pleuroparenchymaler Fibroelastose. 7(4). 222–226.

Nemoto, Kenji, Shuji Oh‐ishi, Tatsuya Akiyama, et al.. (2019). Borderline pulmonary hypertension is associated with exercise intolerance and increased risk for acute exacerbation in patients with interstitial lung disease. BMC Pulmonary Medicine. 19(1). 167–167. 12 indexed citations

Sekine, Akimasa, Hiroaki Satoh, Tae Iwasawa, et al.. (2017). Isolated Brain Metastases as the First Relapse After the Curative Surgical Resection in Non–Small-Cell Lung Cancer Patients With an EGFR Mutation. Clinical Lung Cancer. 19(1). e29–e36. 4 indexed citations

Sekine, Akimasa, et al.. (2016). [MYCOBACTERIUM ABSCESSUS PULMONARY DISEASE: IMPORTANT PATHOGEN INVOLVED IN MICROBIAL SUBSTITUTION DURING THE TREATMENT OF NON-ABSCESSUS MYCOBACTERIAL DISEASE].. PubMed. 91(4). 469–73. 1 indexed citations

10.

Nemoto, Kenji, Shuji Oh‐ishi, Toshihide Inui, et al.. (2016). Long-term improvement during tadalafil therapy in a patient with pulmonary hypertension secondary to pulmonary Langerhans cell histiocytosis. Respiratory Medicine Case Reports. 18. 54–57. 8 indexed citations

11.

Miura, Yukiko, Takefumi Saito, Toru Tanaka, et al.. (2014). Clinical effect of pirfenidone on incidence of lung carcinoma in chronic interstitial pneumonia. European Respiratory Journal. 44(Suppl 58). P3497–P3497. 3 indexed citations

12.

Sekine, Akimasa, Yukio Morishita, Koji Okudela, et al.. (2014). Benign Myoepithelioma in the Intrathoracic Trachea. Internal Medicine. 53(14). 1535–1538. 4 indexed citations

13.

Yamada, Masao, et al.. (2013). Effects of whole body vibration in Japanese patients with chronic obstructive pulmonary disease. A randomized controlled trial. European Respiratory Journal. 42(Suppl 57). P3563–P3563. 1 indexed citations

14.

Sekine, Akimasa, Terufumi Kato, Eri Hagiwara, et al.. (2012). Metastatic brain tumors from non-small cell lung cancer with EGFR mutations: Distinguishing influence of exon 19 deletion on radiographic features. Lung Cancer. 77(1). 64–69. 82 indexed citations

15.

Nawa, Takeshi, Tohru Nakagawa, Tetsuya Mizoue, et al.. (2012). A decrease in lung cancer mortality following the introduction of low-dose chest CT screening in Hitachi, Japan. Lung Cancer. 78(3). 225–228. 43 indexed citations

16.

Furukawa, Kinya, Masaharu Inagaki, Shigemi Ishikawa, et al.. (2011). A population-based study of gefitinib in patients with postoperative recurrent non-small cell lung cancer. Experimental and Therapeutic Medicine. 3(1). 53–59. 1 indexed citations

17.

Kawaguchi, Tomoya, Minoru Takada, Masahiko Ando, et al.. (2011). A multi-institutional phase II trial of consolidation S-1 after concurrent chemoradiotherapy with cisplatin and vinorelbine for locally advanced non-small cell lung cancer. European Journal of Cancer. 48(5). 672–677. 8 indexed citations

18.

Hayashi, Hiroki, Masashi Matsuyama, Nariaki Kokuho, et al.. (2009). [Case of systemic sclerosis sine scleroderma showing pulmonary venula lesion that suggests pulmonary veno-occlusive disease].. PubMed. 47(5). 376–82. 1 indexed citations

19.

Nei, Takahito, et al.. (2007). Microbial substitution of Mycobacterium avium-intracellulare to Mycobacterium abscessus during clinical course. Journal of Infection and Chemotherapy. 13(5). 343–345. 3 indexed citations

20.

Kobayashi, Kunihiko, Shoji Kudoh, Mitsunori Hino, et al.. (1995). In vitro investigation of a combination of two drugs, cisplatin and carboplatin, as a function of the area under thec/t curve. Journal of Cancer Research and Clinical Oncology. 121(12). 715–720. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact